By Reuters Sept 5, 2018 3:25:49 PM IST (Published)
Shares of Sun Pharma Advanced Research Company (SPARC) rise as much as 4.8 percent to Rs 404.9, biggest daily percent gain in nearly a week.
Shares of Sun Pharma Advanced Research Company (SPARC) rise as much as 4.8 percent to Rs 404.9, biggest daily percent gain in nearly a week.
Live Tv
Loading...
Pharma research & development co expects to file with US Food and Drug Administration its new drug application for cancer drug Taclantis by Q4 2019, it said here in a presentation on Tuesday.
Co says deadlines for U.S. FDA to review ocular hypertension drug Xelpros and anti-epileptic agent Elepsia as November 2018 and January 2019, respectively.